Does autologous stem cell transplant treat multiple myeloma?

It can produce a deep response, but it is not generally described as a cure. Some people are not suitable for intensive treatment, and the decision reflects fitness and organ function rather than age alone.

Treatment commonly begins with medicines to bring the myeloma under control. Blood-forming stem cells are then collected from your blood and stored. After high-dose chemotherapy, those cells are infused back through a vein to restore bone marrow function.

The chemotherapy targets myeloma cells; the stem cells act as a rescue for blood production. Further medicine may follow to help maintain the response, depending on the individual treatment strategy.

Expect assessment of blood counts, kidney function, heart and lung health, infections, and how the myeloma has responded. The team will also review pain, mobility, existing nerve symptoms, medicines, and whether stem cell collection is likely to be adequate.

Discuss dental care, fertility, nutrition, work leave, transport, and home support before the transplant period. Take the prescribed infection precautions seriously and check before using herbal products or non-prescription medicines.

Seek urgent guidance from your transplant team for fever or chills, breathing problems, new confusion, uncontrolled sickness or diarrhoea, reduced urine, unexpected bruising or bleeding, severe weakness, or difficulty keeping fluids down. Report increasing redness, tenderness, swelling, or discharge at a line site as well.

You might ask what the transplant is intended to achieve, how kidney health affects the plan, whether maintenance treatment is expected afterward, how existing neuropathy will be managed, and what help you will need during recovery.